A Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure: The COMMANDER HF study

Greenberg Barry; Anker Stefan; Byra William M.; Cleland John G. F.; Fu Min; Gheorghiade Mihai; Lam Carolyn S. P.; Mehra Mandeep R.; Neaton James D.; Nessel Christopher C.; Spiro Theodore; Van Veldhuisen Dirk J.; Zannad Faiez

首页> 外文期刊>Journal of cardiac failure >A Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure: The COMMANDER HF study

【24h】

A Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure: The COMMANDER HF study

机译：一种随机研究，将Rivaroxaban与安慰剂在失效的心力衰竭事件中与心力衰竭和显着的冠状动脉疾病中的一种随机研究：指挥官HF研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of cardiac failure》 |2018年第11期|共1页
作者
Greenberg Barry; Anker Stefan; Byra William M.; Cleland John G. F.; Fu Min; Gheorghiade Mihai; Lam Carolyn S. P.; Mehra Mandeep R.; Neaton James D.; Nessel Christopher C.; Spiro Theodore; Van Veldhuisen Dirk J.; Zannad Faiez;
展开▼
作者单位

Univ Calif San Diego San Diego CA 92103 USA;

Charite Berlin Germany;

Janssen R&

D Raritan NJ USA;

Univ Glasgow Glasgow Lanark Scotland;

Janssen R&

D Raritan NJ USA;

Posthumous Northwestern Univ Chicago IL USA;

Natl Heart Ctr Singapore Singapore;

Harvard Med Sch Boston MA USA;

Univ Minnesota Minneapolis MN USA;

Janssen R&

D Raritan NJ USA;

Bayer US LLC Whippany NJ USA;

Univ Groningen Groningen Netherlands;

Univ Lorraine INSERM CHU Nancy France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
入库时间 2022-08-20 08:52:42

相似文献

外文文献
中文文献
专利

1. A Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure: The COMMANDER HF study [J] . Greenberg Barry, Anker Stefan, Byra William M., Journal of cardiac failure . 2018,第11期

机译：一种随机研究，将Rivaroxaban与安慰剂在失效的心力衰竭事件中与心力衰竭和显着的冠状动脉疾病中的一种随机研究：指挥官HF研究
2. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure [J] . FoxK., FordI., StegP.G., The American heart journal . 2013,第4期

机译：研究的基本原理，设计和基线特征评估了冠状动脉疾病患者中If抑制剂ivabradine的发病率-死亡率（SIGNIFY试验）：稳定冠心病患者使用ivabradine的随机，双盲，安慰剂对照试验没有临床心力衰竭的动脉疾病
3. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure [J] . FoxK., FordI., StegP.G., The American heart journal . 2013,第4期

机译：研究评估冠状动脉疾病患者抑制剂IVABRADINE的发病率，设计和基线特征，评估冠状动脉疾病患者的发病率 - 死亡率（意思是试验）：稳定冠状动脉患者Ivabradine的随机，双盲，安慰剂对照试验没有临床心力衰竭的动脉疾病
4. Improvement of Haemodynamics by ATl-Antagonists-addition to ACE-inhibitor pretreated Patients with Severe Chronic Heart Failure Based on Coronary Artery Disease [C] . B. Gremmler, K. Kisters, M. Kunert, International Congress on Coronary Artery Disease . 2003

机译：基于冠状动脉疾病的ACE抑制剂预处理患者的ATL-拮抗剂改善血液肿瘤
5. Total Brachial Artery Reactivity and Incident Heart Failure and Heart Failure Sub-Types: Multi-Ethnic Study of Atherosclerosis [D] . Segura, Daniela Charry . 2021

机译：总肱动脉反应性和事件心力衰竭和心力衰竭子类型：动脉粥样硬化的多民族研究
6. Rationale and design of a randomized double‐blind event‐driven multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial [O] . Faiez Zannad, Barry Greenberg, John G.F. Cleland, -1

机译：一项随机双盲事件驱动多中心研究的理由和设计该研究比较了口服利伐沙班与安慰剂在降低心衰和严重冠状动脉疾病患者死亡发生心肌梗塞或中风的风险方面的功效和安全性。心力衰竭加重：COMMANDER HF试验
7. Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial [O] . Zannad, Faiez, Greenberg, Barry, Cleland, John G. F., 2015

机译：一项随机，双盲，事件驱动，多中心研究的理由和设计，比较了口服利伐沙班和安慰剂在降低心力衰竭和严重冠状动脉疾病后的死亡，心肌梗塞或中风风险方面的功效和安全性。心力衰竭加重：COMMANDER HF试验

A Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure: The COMMANDER HF study

著录项

相似文献

相关主题

期刊订阅